Exon capture analysis of G protein-coupled receptors identifies activating mutations in GRM3 in melanoma
Top Cited Papers
- 25 September 2011
- journal article
- research article
- Published by Springer Nature in Nature Genetics
- Vol. 43 (11) , 1119-1126
- https://doi.org/10.1038/ng.950
Abstract
Yardena Samuels and colleagues sequenced G protein-coupled receptors in 11 melanoma samples and report a comprehensive map of somatic variants in the GPCR gene family. They find frequent mutations in GRM3, which promote proliferation and migration of melanoma cells. G protein-coupled receptors (GPCRs), the largest human gene family, are important regulators of signaling pathways. However, knowledge of their genetic alterations is limited. In this study, we used exon capture and massively parallel sequencing methods to analyze the mutational status of 734 GPCRs in melanoma. This investigation revealed that one family member, GRM3, was frequently mutated and that one of its mutations clustered within one position. Biochemical analysis of GRM3 alterations revealed that mutant GRM3 selectively regulated the phosphorylation of MEK, leading to increased anchorage-independent growth and migration. Melanoma cells expressing mutant GRM3 had reduced cell growth and cellular migration after short hairpin RNA–mediated knockdown of GRM3 or treatment with a selective MEK inhibitor, AZD-6244, which is currently being used in phase 2 clinical trials. Our study yields the most comprehensive map of genetic alterations in the GPCR gene family.Keywords
This publication has 23 references indexed in Scilit:
- Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic MelanomaClinical Cancer Research, 2009
- Genetic Inactivation of ADAMTS15 Metalloprotease in Human Colorectal CancerCancer Research, 2009
- Analysis of the matrix metalloproteinase family reveals that MMP8 is often mutated in melanomaNature Genetics, 2009
- Estrogen promotes the survival and pulmonary metastasis of tuberin-null cellsProceedings of the National Academy of Sciences, 2009
- G‐protein‐coupled receptors and melanomaPigment Cell & Melanoma Research, 2008
- Multiplex amplification of large sets of human exonsNature Methods, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- BRAF mutation predicts sensitivity to MEK inhibitionNature, 2005
- Multicenter Phase II Study of the Oral MEK Inhibitor, CI-1040, in Patients With Advanced Non-Small-Cell Lung, Breast, Colon, and Pancreatic CancerJournal of Clinical Oncology, 2004
- Melanoma mouse model implicates metabotropic glutamate signaling in melanocytic neoplasiaNature Genetics, 2003